Ignite Creation Date:
2025-12-24 @ 5:51 PM
Ignite Modification Date:
2026-02-22 @ 4:15 PM
Study NCT ID:
NCT01765868
Status:
COMPLETED
Last Update Posted:
2023-08-08
First Post:
2012-12-28
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Human Phase I Absolute Bioavailability Study of PRT054021 in Healthy Male Volunteers
Sponsor:
Portola Pharmaceuticals
Organization:
Study Overview
Official Title:
A Human Phase I Absolute Bioavailability Study of PRT054021 in Healthy Male Volunteers.
Status:
COMPLETED
Status Verified Date:
2023-08
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
This is a open label, single center, single oral dose, study of PRT054021, in healthy subjects.
Detailed Description:
None
Study Oversight
Has Oversight DMC:
False
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?: